MedPath
FDA Product

FLUZONE HIGH DOSE NORTHERN HEMISPHERE

Product approved by U.S. Food and Drug Administration (US)

Basic Information

FLUZONE HIGH DOSE NORTHERN HEMISPHERE

49281-124

Regulatory Information

49281-124

BLA103914

C73585

May 6, 2025

USA

These highlights do not include all the information needed to use Fluzone High-Dose safely and effectively. See full prescribing information for Fluzone High-Dose. Fluzone High-Dose (Influenza Vaccine) Injectable Suspension, for Intramuscular Use 2024–2025 FormulaInitial U.S. Approval: 2009

VACCINE LABEL

5

Company Information

086723285

Active Ingredients

INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED)

Quantity: 60 ug in 0.5 mL

Code: FF9YP4D23C

Class Code: ACTIM

SODIUM PHOSPHATE, DIBASIC, ANHYDROUS

Code: 22ADO53M6F

Class Code: IACT

SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS

Code: KH7I04HPUU

Class Code: IACT

WATER

Code: 059QF0KO0R

Class Code: IACT

OCTOXYNOL-9

Code: 7JPC6Y25QS

Class Code: IACT

FORMALDEHYDE

Code: 1HG84L3525

Class Code: IACT

Active Moieties

INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)

Code: C46XJT9FQ9

INFLUENZA A VIRUS A/CALIFORNIA/122/2022 SAN-022 (H3N2) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)

Code: 8L9R8S52VV

INFLUENZA B VIRUS B/MICHIGAN/01/2021 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)

Code: CQV855H5FG

© Copyright 2025. All Rights Reserved by MedPath